retatrutide what it does VisualAbstract: reduces body weight by 17.5% in patients with obesity What to Know About Retatrutide

Quick Answer: GLP-1 receptor agonists do not directly treat or improve Hashimoto's disease or its underlying autoimmune process, though they may be safely used for appropriate metabolic indications like type 2 diabetes or obesity in patients with this thyroid condition

Semaglutide (Wegovy / Ozempic): Semaglutide for weight loss took several years to move from diabetes approval to obesity indications

I recommend limiting exposure to these comparisons during difficult periods

Reduced caloric intake, weight loss, and metabolic changes all contribute

It may also be easy to underestimate calories from beer, especially with higher-alcohol options

[,] However, since GLP-1 were not initially developed with pregnancy, safety and efficacy data in pregnant remain limited